Drug Substance Manufacturing services
Product Description
Mabion SA
-
Country/Region:Poland
-
On CPHI since:2023
-
Certificates:3
-
Employees:250 - 499
Categories
Specifications
Mabion SA
-
Country/Region:Poland
-
On CPHI since:2023
-
Certificates:3
-
Employees:250 - 499
More Products from Mabion SA (2)
-
Product MabionCD20
This is our most advanced in-house project. A MabThera/Rituxan (rituximab) biosimilar drug, whose efficacy and safety were clinically confirmed. It is the first such advanced drug developed in Poland. We are currently at the final stage of works aimed at marketing the drug in Europe and the United States. -
Product Analytical Services
Mabion offers a extensive suite of Analytical Services to ensure safety, efficacy and quality of your biologic product. Our portfolio includes development, optimization and validation of analytical methods, as well as stability studies, GMP release testing and in-depth drug characterization. In addition to...
Mabion SA resources (2)
-
News A Day in the Life of a Specialist in Biological Analytical Methods
The Day in the Life of series continues with a spotlight on those in the R&D side of things in pharma, a key element to medicine discovery, safety, and manufacture. This interview shines a light on those working in this integral field.
-
Brochure Mabion - Your Biologics CDMO
A description of Mabion's CDMO offering

